Contact
searchSearch
HMP Global
Login

April 2022

Department

Research in Review
Highlights from the Community Oncology Alliance (COA) 2022 Community Oncology Conference
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Lung Cancer
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways

Feature

From the Field
Real-World Characteristics and Outcomes of Patients With Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma Treated With First-Line Bendamustine + Rituximab
04/20/2022
Dr Kotchetkov and colleagues assessed the pattern of B-R administration, efficacy and safety in adult patients with indolent non-Hodgkin lymphoma and mantle cell lymphoma with advanced disease and co-morbidities in the real-world setting.
Dr Kotchetkov and colleagues assessed the pattern of B-R administration, efficacy and safety in adult patients with indolent non-Hodgkin lymphoma and mantle cell lymphoma with advanced disease and co-morbidities in the real-world setting.
Dr Kotchetkov and colleagues...
04/20/2022
Journal of Clinical Pathways

Column

Editor's Page
On the Road Again
04/20/2022
Dr Wong discusses features in this issue, which include insights on ACCC's 48th Annual Meeting & Cancer Business Summit, highlights from COA's Conference, and an article on real-world patterns of B-R administration in patients with iNHL and...
Dr Wong discusses features in this issue, which include insights on ACCC's 48th Annual Meeting & Cancer Business Summit, highlights from COA's Conference, and an article on real-world patterns of B-R administration in patients with iNHL and...
Dr Wong discusses features in...
04/20/2022
Journal of Clinical Pathways
Clinical Pathways GPS
Clinical Pathways: Expanding Beyond Pharmaceuticals
04/20/2022
Dr Stefanacci explains how changes in our clinical pathways will greatly expand our treatment options, providing significant improvement in both clinical and financial outcomes. 
Dr Stefanacci explains how changes in our clinical pathways will greatly expand our treatment options, providing significant improvement in both clinical and financial outcomes. 
Dr Stefanacci explains how...
04/20/2022
Journal of Clinical Pathways
Trending From ACCC
A Focus on Community Oncology Research
04/20/2022
Association of Community Cancer Centers
ACCC Community Oncology Research Institute (ACORI) works to establish clinical trials as a standard of care in treatment plans and will enable community oncology programs and their multidisciplinary teams to access the tools, knowledge...
ACCC Community Oncology Research Institute (ACORI) works to establish clinical trials as a standard of care in treatment plans and will enable community oncology programs and their multidisciplinary teams to access the tools, knowledge...
ACCC Community Oncology Research...
04/20/2022
Journal of Clinical Pathways
Pharma Insights
Big Data Analytics in Health Care and Drug Therapy Management—Opportunities and Considerations
04/20/2022
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues ...
04/20/2022
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

April 2022 Volume 8 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use